Ellen de Haas

Ellen de Haas is an active researcher in the Department of Dermatology at Erasmus University Medical Center (Erasmus MC) in Rotterdam, Netherlands. Her academic profile indicates ongoing research contributions within the university hospital system, with recent publications spanning 2020-2022.

Her research primarily focuses on cutaneous lymphomas and skin cancer treatments, with particular expertise in photodynamic therapy, mycosis fungoides, Sézary syndrome, and topical drug development. Key research areas include:

• Photodynamic therapy optimization for superficial basal cell carcinoma
• Clinical trials of novel topical agents like bimiralisib for cutaneous T-cell lymphoma
• Epidemiological studies of cutaneous lymphoma incidence in the Netherlands
• Management of rare dermatological malignancies including lymphomatoid papulosis

Analysis of her recent publications reveals a strong clinical research trajectory centered on improving therapeutic outcomes for patients with cutaneous malignancies. Her work bridges laboratory pharmacology with clinical dermatology, particularly in developing and evaluating targeted topical treatments for skin cancers and lymphoproliferative disorders.

While no specific scientific awards are listed in her current profile, her research has generated significant academic impact with multiple publications accumulating substantial citations (up to 45 citations for her lymphomatoid papulosis study). Her collaborative network spans multiple Dutch medical institutions with frequent co-authorship among dermatology and oncology specialists at Erasmus MC.

Dr. de Haas maintains active involvement in clinical research teams focused on cutaneous oncology, contributing to both therapeutic development and epidemiological understanding of rare skin malignancies. Her work appears integrated within Erasmus MC's broader dermatology research infrastructure focused on translational skin cancer research.